Ex parte MILLER - Page 5



          Appeal No. 97-0268                                                          
          Application No. 07/991,872                                                  


          dehydrogenation of the type disclosed by Miller.  Secondly,                 
          the appellant's nonobviousness position, with respect to the                
          here                                                                        
          claimed silica to alumina mole ratio specifically, is                       
          unpersuasive because it is contrary to patentee's express                   
          teaching of a ratio range which overlaps that defined by the                
          independent claim on appeal.  Ex parte Lee, 31 USPQ2d 1105,                 
          1107                                                                        
          (Bd. Pat. App. & Int. 1993).  Indeed with regard to this                    
          ratio,                                                                      
          the Miller disclosure of values within the here claimed range               
          is                                                                          
          considered to be an anticipation of this claimed range.  Ex                 
          parte                                                                       
          Lee, 31 USPQ2d at 1106.  Finally, concerning this last                      
          mentioned point, we emphasize that the question raised by the               
          appellant as to whether the Miller reference teaches away from              
          the here claimed ratio is simply inapplicable to an                         
          anticipation analysis. Celeritas Technologies Ltd. v. Rockwell              
          International Corp., 150 F.3d 1354, 1361, 47 USPQ2d 1516, 1522              
          (Fed. Cir. 1998).                                                           



                                             5                                        




Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007